PHACE - Prospective Genetic Investigation
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Nov 12, 2021
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Subjects with PHACE syndrome diagnosis will undergo a brief physical examination with possible external photographs. Cheek swabs will be sent for genetic analysis. Subjects will be notified of the results.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • PHACE syndrome diagnosis
- • Must be willing to have an eye examination
- • Must be willing to undergo genetic testing
- Exclusion Criteria:
- • No PHACE syndrome diagnosis
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Karen Joos, MD, PhD
Principal Investigator
Vanderbilt Eye Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials